Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension

• Status: Completed
• Trial end date: 2013-08-01

Summary

This study will be compare Felodipine sustained-release tablets, to Lercanidipine hydrochloride tablets (Zanidip®) for the treatment of patients with mild-to-moderate primary hypertension and to investigate the influence on patients' heart rate and blood pressure variability.

• Phase: Phase 4

Details

• Lead Sponsor: Lee's Pharmaceutical Limited
• Treatments: Felodipine; Lercanidipine